AGISTEN V 0.2 G. VAGINAL TABLETS

국가: 이스라엘

언어: 영어

출처: Ministry of Health

유효 성분:

CLOTRIMAZOLE

제공처:

PADAGIS ISRAEL PHARMACEUTICALS LTD, ISRAEL

ATC 코드:

G01AF02

약제 형태:

VAGINAL TABLETS

구성:

CLOTRIMAZOLE 200 MG

관리 경로:

VAGINAL

처방전 유형:

Not required

Manufactured by:

PADAGIS ISRAEL PHARMACEUTICALS LTD, ISRAEL

치료 그룹:

CLOTRIMAZOLE

치료 영역:

CLOTRIMAZOLE

치료 징후:

Vaginal fungal infections caused mainly by candida species. Vaginal infections caused by trichomonas and microorganisms sensitive to clotrimazole.

승인 날짜:

2022-08-31

제품 특성 요약

SUMMARY OF PRODUCT CHARACTERISTICS
1 .NAME OF THE MEDICINAL PRODUCT
Agisten V 2% Vaginal Cream
2 .QUALITATIVE AND QUANTITATIVE COMPOSITION
Cltorimazole 2%
Excipient with known effect: Cetostearyl alcohol, Benzyl alcohol
For full list of excipients, see section 6.1
3 .PHARMACEUTICAL FORM
VAGINAL CREAM
4 .CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
Broad spectrum antimycotic with fungicidal action
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
One applicator charge daily (approximately 5 g) should be introduced
as deep as
possible into the vagina before retiring for 3 consecutive days. This
is best
achieved when lying on the back
.
Male Partner
The vaginal cream should be applied 2-3 times a day in a thin layer on
the penis
for balanitis (whether symptomatic or asymptomatic). The normal period
of
treatment is 1-2 weeks.
GENERALLY
•
If symptoms persist for more than 7 days the patient may have a
medical
condition that requires treatment by a doctor
•
The treatments can be repeated if necessary however recurrent
infections
may indicate an underlying medical cause, including diabetes or HIV
infections. Patients should seek the medical advice if symptoms return
within
2 months
•
Since the vagina and vulva are usually both affected, a combination
treatment
(treatment of both of these areas) should be performed
•
Treatment during the menstrual period should not be performed. The
treatment should be finished before the onset of menstruation
•
If the labia and adjacent areas are simultaneously infected, local
treatment
with an external cream should also be given. The sexual partner should
also
undergo local treatment if symptoms, e.g. pruritus, inflammation, etc.
are
present
•
Do not use tampons, intravaginal douches, spermicidies or other
vaginal
products while using this product
.
•
Avoidance of vaginal intercourse is recommended while using this
product
because the infection could be transferred to your partner, and the
effectiveness and safety of latex products such as condoms and
diaphragms
may be reduce